Latest Memorial Sloan–Kettering Cancer Center Stories
NEW YORK, Sept. 27 /PRNewswire-USNewswire/ -- The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research will honor several leaders at its 35th Annual Awards Gala on Wednesday, October 27th, 2010 at the Marriott Marquis Times Square in Manhattan.
A blood test at the age of 60 can accurately predict the risk that a man will die from prostate cancer within the next 25 years.
A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer's disease (AD).
A multicenter study has concluded that treatment with a new targeted therapy called PLX4032 (also called RG7204) resulted in significant tumor shrinkage in 80 percent of patients with advanced melanoma.
A unique collaboration among physician-scientists at Memorial Sloan-Kettering Cancer Center (MSKCC) has yielded the most comprehensive genomic analysis of prostate cancer to date.
NEW YORK, April 21 /PRNewswire/ -- The Kristen Ann Carr Fund has awarded a grant to Jonathan Lewis, MD, PhD, Chief Executive Officer and Chief Medical Officer of ZIOPHARM Oncology, Inc., which will fund translational work at the Memorial Sloan-Kettering Cancer Center and the Albert Einstein College of Medicine in New York City, for the development of a novel treatment for pediatric sarcoma.
An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer.
PHILADELPHIA, April 7 /PRNewswire/ -- The Sidney Kimmel Foundation for Cancer Research has selected fifteen scientists from across the United States to receive two-year grants under the Foundation's on-going Kimmel Scholar program.
HACKENSACK, N.J., April 5 /PRNewswire/ -- John Theurer Cancer Center at Hackensack University Medical Center will bring together top neuro-oncologists from around the country for a symposium to address new treatment updates and review management of complex cases across a broad array of neuro-oncology specialties.
Nearly half of colon cancer patients will develop liver metastases; the majority will not be candidates for surgeryâ€”interventional radiology treatment destroys cancer locally, extends life.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.